Literature DB >> 19782670

Down-regulation of dicer expression in ovarian cancer tissues.

Georgios Pampalakis1, Eleftherios P Diamandis, Dionyssios Katsaros, Georgia Sotiropoulou.   

Abstract

OBJECTIVES: Although numerous recent studies have focused on analyses of microRNA expression profiles in cancer cells, the expression patterns of the enzymes responsible for the generation of miRNAs remains largely unexplored. The purpose of this study was to investigate whether Dicer mRNA expression is altered during progression of ovarian cancer. DESIGN AND METHODS: Total RNA was extracted from ovarian tissue specimens (normal, benign and malignant tumors). The expression of Dicer was analyzed by semi-quantitative RT-PCR.
RESULTS: We analyzed a total of 34 ovarian tissue samples and found that Dicer mRNA expression is down-regulated in the majority of ovarian tumors when compared to normal tissues.
CONCLUSIONS: Our results suggest that the levels of Dicer mRNA should be evaluated as a potential new candidate biomarker for ovarian cancer. (c) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782670     DOI: 10.1016/j.clinbiochem.2009.09.014

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  54 in total

1.  The potential role of microRNAs in regulating gonadal sex differentiation in the chicken embryo.

Authors:  Andrew D Cutting; Stephanie C Bannister; Tim J Doran; Andrew H Sinclair; Mark V L Tizard; Craig A Smith
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

Review 2.  Dysregulation of microRNA biogenesis machinery in cancer.

Authors:  Akiko Hata; Risa Kashima
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-12-01       Impact factor: 8.250

Review 3.  Minireview: The roles of small RNA pathways in reproductive medicine.

Authors:  Shannon M Hawkins; Gregory M Buchold; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2011-05-05

Review 4.  MicroRNA biogenesis pathways in cancer.

Authors:  Shuibin Lin; Richard I Gregory
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

5.  Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer.

Authors:  Clare M Adams; Christine M Eischen
Journal:  Cancer Res       Date:  2014-05-19       Impact factor: 12.701

6.  Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.

Authors:  Ying Zhu; Liqiong Cai; Jing Guo; Na Chen; Xiaoqing Yi; Yong Zhao; Jing Cai; Zehua Wang
Journal:  Tumour Biol       Date:  2016-08-05

7.  Silencing the double-stranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion.

Authors:  Yuqi Guo; Peng Tian; Chuanhe Yang; Zhibing Liang; Min Li; Michelle Sims; Lu Lu; Zhan Zhang; Hongwei Li; Lawrence M Pfeffer; Junming Yue
Journal:  Pharm Res       Date:  2015-03       Impact factor: 4.200

Review 8.  The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.

Authors:  Xiyin Wang; Mircea Ivan; Shannon M Hawkins
Journal:  Gynecol Oncol       Date:  2017-08-31       Impact factor: 5.482

9.  Dysregulation of microRNA biosynthesis enzyme Dicer plays an important role in gastric cancer progression.

Authors:  Jin Zhang; Xin-Hua Zhang; Cai-Xia Wang; Biao Liu; Xiang-Shan Fan; Juan-Juan Wen; Qun-Li Shi; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

10.  Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.

Authors:  I Lambertz; D Nittner; P Mestdagh; G Denecker; J Vandesompele; M A Dyer; J-C Marine
Journal:  Cell Death Differ       Date:  2009-12-18       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.